Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Martin Makary
Pharma
FDA takes close look at mifepristone REMS program
After being pushed by AGs from 22 states, U.S. healthcare leaders are taking another look at the dispensing guidelines for mifepristone.
Eric Sagonowsky
Sep 25, 2025 11:00am
FDA urges doctors to minimize Tylenol use during pregnancy
Sep 23, 2025 8:55am
Pfizer, Moderna score updated COVID vaccine approvals from FDA
Aug 27, 2025 3:26pm
FDA rolls out daily updates to adverse event dashboard
Aug 25, 2025 10:36am
FDA debuts new program to ease US manufacturing plant setup
Aug 7, 2025 3:16pm
FDA taps George Tidmarsh to lead CDER
Jul 21, 2025 10:53am